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errucous sarcoidosis (VS) is a rare variant
of cutaneous sarcoidosis that most often
appears on the lower extremities. It could
represent a localized hypertrophic response over
an area with underlying noncaseating sarcoidal
granulomas or a response secondary to a viral
wart overlying a sarcoidal plaque. A case of
annular VS on the face is reported in the setting
of widespread background cutaneous papular and
plaque sarcoidosis.
CASE REPORT
A 51-year old African-American woman with a
history of pulmonary sarcoidosis for more than a
decade presented for evaluation of a facial rash. The
rash had been present for several years and failed to
respond to hydrocortisone 2.5% cream twice daily
during this period. A laceration on the nasal bridge
induced by blunt trauma from the nose pad of her
eyeglasses occurred immediately before the appear-
ance of expanding verrucous papillomatous changes
in this area. She had no personal or family history of
warts.
An annular plaque with verrucous surface fea-
tures and central clearing was present on the bridge
of the nose (Fig 1, A and B). Numerous skin-colored
to violaceous papules and plaques, all demon-
strating a smooth surface, were distributed on the
forehead, temples, chin, and cheeks (Fig 1, A and B).Southeastern University, Fort Lauderdalea; VCOM/Lewis-Gale
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plaque on the right cheek showed sarcoidal granu-
lomas. Periodic acid-Schiff and Acid-Fast Bacilli
stains showed no offending organisms, and no
polarizable foreign material was present. A 4-mm
punch biopsy from the verrucous lesion on the
bridge of the nose demonstrated hyperkeratosis,
acanthosis, hypergranulosis, and papillomatosis
with parakeratosis overlying digitate projections of
epithelium. Mild vacuolization of the granular layer
was noted between the projections. Sarcoidal gran-
ulomas, composed of histiocytes including scattered
multinucleated giant cells, were present in the un-
derlying dermis surrounded by a few scattered
lymphocytes (Fig 2, A and B).
Sections from the punch biopsy of the verrucous
lesion were sent for DNA quality assessment by
b-globin reference gene polymerase chain reaction
(PCR). DNA quality assessment was positive, and
human papillomavirus (HPV) typing by PCR
using the nested primer system was performed.1
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Fig 1. A, An annular verrucous plaque with central clearing slowly expanded over several
years after blunt trauma to the bridge of the nose. B, Scattered 1- to 8-mm hyperpigmented
dermal papules and plaques without scaling on the cheeks.
Fig 2. A, Epidermis shows papillomatous architecture with hyperkeratosis and acanthosis.
Parakeratosis overlies digitate projections (left pointing arrow) of epithelium. Hypergranulosis
with vacuolization presents between the projections. A sarcoidal granuloma (downward
arrow) is noted in the upper dermis. B, Sarcoidal granulomas with multinucleated giant cells
are surrounded by a sprinkling of lymphocytes. (A and B, Hematoxylin-eosin stain; original
magnifications: A, 340; B, 3100.)
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extracted from the tissue sample, and the HPV-PCR
product obtained from the sample was cloned and
sequenced. The National Center for Biotechnology
Information Basic Local Alignment Search Tool
(NCBIBLAST) analysis of the sequence information
obtained from the clones found the presence of HPV
type candidate FA14 (Fig 3, A-C).
Imiquimod 5% cream 3 times a week was
initiated but then discontinued because of severe
irritation after 2 weeks. The cutaneous sarcoidosis
was treated with hydroxychloroquine, 200 mg
orally twice a day. Three months later, the patient
returned after being lost to follow-up. The original
annular verrucous lesion expanded, and 2 new
annular verrucous lesions appeared overlying areas
in which previous sarcoidal papules and plaques
had been present (Fig 4, A-C). Despite the new and
expanding verrucous lesions, the background
smooth-surfaced sarcoidal papules and plaques
had improved 80% to 90% since her previous visit.
Treatment with imiquimod 5% cream was restartedonce weekly to verrucous areas, and hydroxychlor-
oquine was continued.
DISCUSSION
Sarcoidosis is known as one of the great imitators,
with skin findings occurring in 20% to 35% of cases.
In some cases, skin lesions are the only manifestation
of sarcoidosis.2,3 These cutaneous findings are clas-
sified as specific when they are associated with
cutaneous granulomas (Table I). The maculopapular
form is the most common specific dermatologic
manifestation of sarcoidosis.3 Nonspecific dermato-
logic manifestations of sarcoidosis are not associated
with granulomas (see Table I).3,4 Erythema nodosum
is the most common nonspecific dermatologic mani-
festation of sarcoidosis.3,4
VS is a rare, specific form of cutaneous sarcoid-
osis usually occurring in association with severe
pulmonary disease.4,5 It most commonly affects the
lower extremities.4,6 The differential diagnoses for
verrucous sarcoidosis include verruca vulgaris, hy-
pertrophic lichen planus, prurigo nodularis, and
Fig 3. A, The patient’s DNAwas positive with b-globin PCR assay. B, The patient’s sample was
positive with FAP-nested PCR assay designed primarily for the detection of cutaneous HPVs.
C, National Center for Biotechnology Information Basic Local Alignment Search Tool analysis
of DNA sequence information obtained from the 235 base pairesized HPV-PCR product found
the presence of FA14 HPV isolate in the patient’s sample.
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mycobacterial diseases.2,4
The pathophysiologic basis of VS is not clear.
The verrucous epidermal response seen on histo-
pathology could represent an alteration in cuta-
neous response to persistent mechanical irritation
and, therefore, characterizes a type of hypertro-
phic localized neurodermatitis.7 A similar mecha-
nism has been proposed for the epidermal change
in psoriasiform sarcoidosis.8 The patient in this
case did not complain of pruritus and denied
rubbing the lesions. Furthermore, HPV was iden-
tified in this case supporting viral etiology of the
verrucous hyperplasia.
Second, the HPV could serve as a sarcoidal
priming antigen initiating the underlying cutaneoussarcoidosis.9-11 Of course, in this case, most facial
cutaneous sarcoidal papules and plaques were not
associated with overlying verrucous change. It is
unlikely that 2 priming antigens were present.
A third explanation appears to be the most likely.
The verrucous change may have been initiated by
local inoculation of HPV after eyeglass trauma. The
HPV then preferentially spread and rapidly grew in
previously formed sarcoidal plaques. These plaques
may represent immunocompromised districts.12
First, the granulomatous inflammatory process in
the dermis may suppress immunemechanisms in the
epidermis potentiating the growth of the virus.
Second, the immunosuppressive effects of topical
steroid treatment may have played a role in viral
propagation and spread. This explanation is
Fig 4. A, Expansion of the original annular verrucous lesion. Two newer-appearing annular
verrucous lesions, one just lateral to the left nasolabial fold and the other superior to the left
lateral eyebrow arose in pre-existing sarcoidal plaques. Note the improvement in the
background cutaneous sarcoidosis papules and plaques. (Compare with Fig 1, A and B.)
B, Close-up view of the annular verrucous lesion along the right nasal sidewall. C, Close-up
view of the annular verrucous lesion superior to the left lateral eyebrow.
Table I. Dermatologic findings in sarcoidosis
Specific manifestations Nonspecific manifestations
Maculopapular Erythema nodosum
Plaque Calcifications
Nodular Prurigo
Annular Erythema multiforme
Lupus pernio Nail clubbing
Cicatricial/scar Sweet’s syndrome
Scarring alopecia
Ulcerative
Ichthyosiform
Erythrodermic
Subcutaneous
Morpheaform
Mucosal
Verrucous
Psoriasiform
Lichenoid
Angiolupoid
Nail dystrophy
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areas overlying previous cutaneous sarcoidal granu-
lomas without interval trauma at these sites.
A limitation of the positive HPV tissue sample is
the finding of HPV FA14 in healthy skin and in the
skin of immunocompromised renal transplant pa-
tients.13 On the other hand, the clinical appearance,
expansive growth, and Hematoxylin-eosin stain
findings support the viral etiology of these verrucous
lesions. To the best of our knowledge, this is the first
time HPV has been confirmed in verrucous sarcoid-
osis. Studies should be performed to determine if this
is an unusual finding or if HPV is present in many
cases of verrucous sarcoidosis. In addition to better
understanding the pathophysiologic basis of this
condition, the presence of HPV-associated verrucoussarcoidosis in some patients would lead to more
focused prevention and treatment options.
REFERENCES
1. Forslund O, Ly H, Higgins G. Improved detection of cutaneous
human papillomavirus DNA by single tube nested ‘hanging
droplet’ PCR. J Virol Methods. 2003;110(2):129-136.
2. Tchernev G, Patterson JW, Nenoff P, Horn LC. Sarcoidosis of
the skin— a dermatological puzzle: important differential
diagnostic aspects and guidelines for clinical and histopath-
ological recognition. J Eur Acad Dermatol Venereol. 2010;24(2):
125-137.
3. Lodha S, Sanchez M, Prystowsky S. Sarcoidosis of the skin: a
review for the pulmonologist. Chest. 2009;136(2):583-596.
4. DeFelice T, Fischer M, Kamino H, Cohen D, Latkowski JA.
Verrucous and macular sarcoidosis. Dermatol Online J. 2012;
18(12):10.
5. Corradin MT, ForcioneM, Fiorentino R, BordignonM, AlaibacM,
Belloni-Fortina A. Verrucous cutaneous sarcoidosis in an adoles-
cent with dark skin. Eur J Dermatol. 2010;20(5):659-660.
6. Irgang S. Verrucous and papillomatous types of sarcoid; report
of a case. Arch Derm Syphilol. 1950;62(1):105-108.
7. Shaffer B, Beerman H. Lichen simplex chronicus and its
variants; a discussion of certain psychodynamic mechanisms
and clinical and histopathologic correlations. AMA Arch Derm
Syphilol. 1951;64(3):340-351.
8. Murphy GF, Herzberg AJ. Psoriasiform dermatitis. In:
Murphy GF, Herzberg AJ, eds. Dermatopathology. Philadelphia:
WB Saundars and Co; 1996:49-50.
9. Okamoto H. Epidermal changes in cutaneous lesions of
sarcoidosis. Am J Dermatopathol. 1999;21(3):229-233.
10. Martin AG, Kleinhenz ME, Elmets CA. Immunohistologic
identification of antigen-presenting cells in cutaneous sarcoid-
osis. J Invest Dermatol. 1986;86(6):625-629.
11. Mahony J, Helms SE, Brodell RT. The sarcoidal granuloma: a
unifying hypothesis for an enigmatic response. Clin Dermatol.
2014;32(5):654-659.
12. Lo Schiavo A, Ruocco E, Gambardella A, O’Leary RE, Gee S.
Granulomatous dysimmune reactions (sarcoidosis, granuloma
annulare, and others) on differently injured skin areas. Clin
Dermatol. 2014;32(5):646-653.
13. Hazard K, Karlsson A, Andersson K, Ekberg H, Dillner J,
Forslund O. Cutaneous human papillomaviruses persist on
healthy skin. J Invest Dermatol. 2007;127(1):116-119.
